Ichor Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Ichor Biologics's estimated annual revenue is currently $12.7M per year.
- Ichor Biologics's estimated revenue per employee is $155,000
Employee Data
- Ichor Biologics has 82 Employees.
- Ichor Biologics grew their employee count by -15% last year.
Ichor Biologics's People
| Name | Title | Email/Phone |
|---|
Ichor Biologics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Ichor Biologics?
Ichor Biologics specializes in the development of therapeutic monoclonal antibodies to treat infectious diseases. Our company has developed a platform for characterizing and isolating pathogen-specific antibodies from convalescent patients. This platform allows us to preserve neutralizing and non-neutralizing antibody functions, thereby increasing the likelihood of in-vivo efficacy. Our initial disease targets include viral infections, such as Hantaviruses and HBV.
keywords:N/A
N/A
Total Funding
82
Number of Employees
$12.7M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.7M | 82 | -6% | N/A |
#2 | $11.2M | 82 | 6% | $10M |
#3 | $10.7M | 82 | 5% | $66M |
#4 | $35M | 82 | -2% | N/A |
#5 | $18.7M | 82 | 44% | N/A |